DK1492796T3 - Substituerede aminoisoxazolinderivater og deres anvendelse som antidepressive midler - Google Patents
Substituerede aminoisoxazolinderivater og deres anvendelse som antidepressive midlerInfo
- Publication number
- DK1492796T3 DK1492796T3 DK03714897T DK03714897T DK1492796T3 DK 1492796 T3 DK1492796 T3 DK 1492796T3 DK 03714897 T DK03714897 T DK 03714897T DK 03714897 T DK03714897 T DK 03714897T DK 1492796 T3 DK1492796 T3 DK 1492796T3
- Authority
- DK
- Denmark
- Prior art keywords
- aminoisoxazoline
- antidepressants
- derivatives
- substituted
- substituted aminoisoxazoline
- Prior art date
Links
- XPZOKPQZEPSMFC-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazol-3-amine Chemical class NC1=NOCC1 XPZOKPQZEPSMFC-UHFFFAOYSA-N 0.000 title 1
- 239000000935 antidepressant agent Substances 0.000 title 1
- 229940005513 antidepressants Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02076239 | 2002-04-02 | ||
| PCT/EP2003/003245 WO2003082878A1 (en) | 2002-04-02 | 2003-03-27 | Substituted amino isoxazoline derivatives and their use as anti-depressants. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1492796T3 true DK1492796T3 (da) | 2007-12-03 |
Family
ID=28459528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03714897T DK1492796T3 (da) | 2002-04-02 | 2003-03-27 | Substituerede aminoisoxazolinderivater og deres anvendelse som antidepressive midler |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7265103B2 (da) |
| EP (1) | EP1492796B1 (da) |
| JP (1) | JP4580653B2 (da) |
| KR (1) | KR20040093061A (da) |
| CN (1) | CN100349897C (da) |
| AR (1) | AR039207A1 (da) |
| AT (1) | ATE372342T1 (da) |
| BR (1) | BR0308309A (da) |
| CA (1) | CA2480113C (da) |
| DE (1) | DE60316134T2 (da) |
| DK (1) | DK1492796T3 (da) |
| EA (1) | EA008189B1 (da) |
| ES (1) | ES2292949T3 (da) |
| HK (1) | HK1080072A1 (da) |
| HR (1) | HRP20040871A2 (da) |
| IL (2) | IL164341A0 (da) |
| MX (1) | MXPA04008626A (da) |
| NO (1) | NO20044645L (da) |
| NZ (1) | NZ536109A (da) |
| PL (1) | PL211708B1 (da) |
| PT (1) | PT1492796E (da) |
| TW (1) | TWI286138B (da) |
| WO (1) | WO2003082878A1 (da) |
| ZA (1) | ZA200407904B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR040967A1 (es) * | 2002-08-12 | 2005-04-27 | Janssen Pharmaceutica Nv | Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos |
| US7462717B2 (en) * | 2002-08-21 | 2008-12-09 | Janssen Pharmaceutica N.V. | C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants |
| US7635696B2 (en) | 2004-11-26 | 2009-12-22 | Janssen Pharmaceutica N.V. | Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity |
| KR101150628B1 (ko) * | 2007-07-03 | 2012-05-31 | 에프. 호프만-라 로슈 아게 | 4-이미다졸린 및 항우울제로서 이의 용도 |
| WO2010104194A1 (en) | 2009-03-10 | 2010-09-16 | Takeda Pharmaceutical Company Limited | Benzofuran derivatives |
| US20130062732A1 (en) | 2011-09-08 | 2013-03-14 | International Business Machines Corporation | Interconnect structures with functional components and methods for fabrication |
| CN105801510A (zh) * | 2016-04-08 | 2016-07-27 | 李勇 | 一种治疗抑郁症的药物组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68906340T2 (de) | 1988-09-19 | 1993-08-12 | Akzo Nv | Tetrahydronaphthalin und indan-derivate. |
| HUP9903706A3 (en) | 1996-01-05 | 2000-09-28 | Hoechst Marion Roussel Inc Cin | 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity, process for their preparation and pharmaceutical compositions containing the same |
| US6187774B1 (en) * | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
| ATE337322T1 (de) * | 2001-02-21 | 2006-09-15 | Janssen Pharmaceutica Nv | Isoxazolin-derivate als antidepressiva |
| AR040967A1 (es) * | 2002-08-12 | 2005-04-27 | Janssen Pharmaceutica Nv | Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos |
| US7462717B2 (en) * | 2002-08-21 | 2008-12-09 | Janssen Pharmaceutica N.V. | C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants |
-
2003
- 2003-03-27 DE DE60316134T patent/DE60316134T2/de not_active Expired - Lifetime
- 2003-03-27 JP JP2003580343A patent/JP4580653B2/ja not_active Expired - Fee Related
- 2003-03-27 KR KR10-2004-7012757A patent/KR20040093061A/ko not_active Ceased
- 2003-03-27 BR BR0308309-8A patent/BR0308309A/pt not_active IP Right Cessation
- 2003-03-27 HR HR20040871A patent/HRP20040871A2/hr not_active Application Discontinuation
- 2003-03-27 PL PL371630A patent/PL211708B1/pl unknown
- 2003-03-27 US US10/510,220 patent/US7265103B2/en not_active Expired - Lifetime
- 2003-03-27 CN CNB038074192A patent/CN100349897C/zh not_active Expired - Fee Related
- 2003-03-27 MX MXPA04008626A patent/MXPA04008626A/es active IP Right Grant
- 2003-03-27 HK HK05112213.1A patent/HK1080072A1/zh unknown
- 2003-03-27 AT AT03714897T patent/ATE372342T1/de not_active IP Right Cessation
- 2003-03-27 DK DK03714897T patent/DK1492796T3/da active
- 2003-03-27 EA EA200401297A patent/EA008189B1/ru not_active IP Right Cessation
- 2003-03-27 NZ NZ536109A patent/NZ536109A/en unknown
- 2003-03-27 WO PCT/EP2003/003245 patent/WO2003082878A1/en not_active Ceased
- 2003-03-27 EP EP03714897A patent/EP1492796B1/en not_active Expired - Lifetime
- 2003-03-27 CA CA2480113A patent/CA2480113C/en not_active Expired - Fee Related
- 2003-03-27 IL IL16434103A patent/IL164341A0/xx unknown
- 2003-03-27 ES ES03714897T patent/ES2292949T3/es not_active Expired - Lifetime
- 2003-03-27 PT PT03714897T patent/PT1492796E/pt unknown
- 2003-04-01 TW TW092107328A patent/TWI286138B/zh not_active IP Right Cessation
- 2003-04-01 AR ARP030101126A patent/AR039207A1/es unknown
-
2004
- 2004-09-28 IL IL164341A patent/IL164341A/en not_active IP Right Cessation
- 2004-09-30 ZA ZA200407904A patent/ZA200407904B/xx unknown
- 2004-10-27 NO NO20044645A patent/NO20044645L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI286138B (en) | 2007-09-01 |
| IL164341A0 (en) | 2005-12-18 |
| HK1080072A1 (zh) | 2006-04-21 |
| EA008189B1 (ru) | 2007-04-27 |
| EP1492796B1 (en) | 2007-09-05 |
| ES2292949T3 (es) | 2008-03-16 |
| PL211708B1 (pl) | 2012-06-29 |
| ATE372342T1 (de) | 2007-09-15 |
| DE60316134T2 (de) | 2008-05-29 |
| MXPA04008626A (es) | 2004-12-06 |
| NO20044645L (no) | 2004-10-27 |
| CA2480113A1 (en) | 2003-10-09 |
| US20050222125A1 (en) | 2005-10-06 |
| PL371630A1 (en) | 2005-06-27 |
| EP1492796A1 (en) | 2005-01-05 |
| US7265103B2 (en) | 2007-09-04 |
| NZ536109A (en) | 2006-06-30 |
| IL164341A (en) | 2009-06-15 |
| KR20040093061A (ko) | 2004-11-04 |
| JP2005522469A (ja) | 2005-07-28 |
| AR039207A1 (es) | 2005-02-09 |
| WO2003082878A1 (en) | 2003-10-09 |
| HRP20040871A2 (en) | 2005-04-30 |
| DE60316134D1 (de) | 2007-10-18 |
| JP4580653B2 (ja) | 2010-11-17 |
| ZA200407904B (en) | 2005-10-20 |
| EA200401297A1 (ru) | 2005-02-24 |
| CN1642960A (zh) | 2005-07-20 |
| BR0308309A (pt) | 2004-12-28 |
| CA2480113C (en) | 2012-04-24 |
| PT1492796E (pt) | 2007-11-16 |
| TW200406414A (en) | 2004-05-01 |
| AU2003219111A1 (en) | 2003-10-13 |
| CN100349897C (zh) | 2007-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1478629T3 (da) | N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler | |
| DK1480955T3 (da) | O-cyclopropyl-carboxanilider og deres anvendelse som fungicider | |
| DK1660491T3 (da) | Benzimidazol-, benzthiazol- og benzoxazolderivater og deres anvendelse som LTA4Hmodulatorer | |
| DK1539712T3 (da) | Pyrimidinderivater og deres anvendelse som CB2-modulatorer | |
| NO20053356L (no) | Aminindazolderivater og anvendelse derav som kinaseinhibitorer. | |
| DK1789401T3 (da) | Isoxazolinderivater og deres anvendelse som herbicider | |
| NO20044137L (no) | Aminoindazolderivater, deres fremstilling og anvendelse samt mellomprodukter | |
| DK2305250T3 (da) | Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer | |
| NO20053215D0 (no) | Pyrazolderivater med anvendelse som COX-1-inhibitorer. | |
| NO20050426L (no) | Arylkarbonylderivater som terapeutiske midler | |
| DK1594867T3 (da) | Phenylacetamider og deres anvendelse som glucokinasemodulatorer | |
| DK1492785T3 (da) | 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer | |
| DK1501815T3 (da) | Substituerede phenylacetamider og anvendelse deraf som glucokinaseaktivatorer | |
| DK1723128T3 (da) | Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer | |
| DK1558615T3 (da) | Purin-forbindelser og deres anvendelse som cannabinoid receptor ligander | |
| DK1480962T3 (da) | 5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer | |
| DK1246802T3 (da) | 4-aminopicolinater og deres anvendelse som herbicider | |
| DK1500654T3 (da) | Benzoxazinonderivater, fremstilling deraf og anvendelse deraf som lægemidler | |
| NO20052995D0 (no) | 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer. | |
| NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
| DK1670458T3 (da) | 1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika | |
| DK1581518T3 (da) | Substituerede 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazin-derivater og deres anvendelse som neurokinin antagonister | |
| DK1636228T3 (da) | Nye pyridopyraziner og deres anvendelse som kinasemodulatorer | |
| NO20043580D0 (no) | Quinazolinonderivater og deres bruk som CB agonister | |
| DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler |